NDC 71205-776 – Emtricitabine and Tenofovir Disoproxil Fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC71205-776

Product details

Brand name
Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Proficient Rx LP
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA090513
Marketed since
March 30, 2021
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (5)

Package NDCDescriptionSince
71205-776-033 TABLET, FILM COATED in 1 BOTTLE (71205-776-03)Oct 4, 2024
71205-776-077 TABLET, FILM COATED in 1 BOTTLE (71205-776-07)Mar 15, 2023
71205-776-3030 TABLET, FILM COATED in 1 BOTTLE (71205-776-30)Mar 15, 2023
71205-776-6060 TABLET, FILM COATED in 1 BOTTLE (71205-776-60)Mar 15, 2023
71205-776-9090 TABLET, FILM COATED in 1 BOTTLE (71205-776-90)Mar 15, 2023

Other Emtricitabine and tenofovir disoproxil fumarate products